Renewal of the Board of Directors
Christina Stercken and Dr Harald Deutsch proposed as new Board Members of Ascom Holding AG.
Ascom wants to strengthen its position in the global healthcare industry as well as continue to grow in new markets. Therefore the Board of Directors proposes with Christina Stercken and Dr Harald Deutsch two new candidates to be elected as Members of the Board of Directors. Both candidates have an impressive international track record.
The Board of Directors further proposes to the Annual General Meeting that the four current members of the Board, Juhani Anttila, Dr J.T. Bergqvist, Cornelia Gehrig and Andreas Umbach be re-elected for a further one-year term of office. Thus the Board of Directors continues to consist of six members.
Moreover, the Board of Directors proposes to the Annual General Meeting to re-elect Juhani Anttila as Chairman of the Board. Andreas Umbach and Dr J.T Bergqvist are proposed to be elected as Members of the Compensation Committee.
Paul E. Otth, Vice Chairman of the Board, has reached the Company's age limit and therefore cannot stand for re-election. Kenth-Ake Jönsson decided not to stand for reelection for personal reasons. The Board of Directors thanks the leaving Board Members for their precious contributions to Ascom.
The invitation to the Annual General Meeting of 1 April 2014 will be published on 11 March 2014.
This document does not constitute an offer or solicitation to subscribe for, purchase or sell any securities. This document is not being issued in the United States of America or the United Kingdom and should not be distributed in any jurisdiction in a manner where such distribution would not comply with regulatory requirements. In particular, this document may not be distributed into the United States, to United States persons or to publications with a general circulation in the United States. In addition, the securities of Ascom have not been and will not be registered in any jurisdiction outside Switzerland. The securities of Ascom may not be offered, sold or delivered and no solicitation to purchase such securities may be made within the United States or to U.S. persons absent an applicable exemption from the registration requirements of the United States securities laws or within any other jurisdiction and in a manner where such offer, sale, delivery or solicitation might not be in compliance with regulatory requirements (including the United Kingdom).